Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
deals
fda
3
×
life sciences
3
×
national blog main
national top stories
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
akouos
allergan
amag pharmaceuticals
ambys medicines
amicus therapeutics
What
help
3
×
bio
patients
roundup
acquisitions
analytics
announced
aren’t
biofourmis
ceo
collabs
covid
daniel
data
deal
developers
devices
digital
drug
drugs
employs
fda
gene
gilead
gilead’s
globally
hauls
imminent
introduce
ipo
long
medicare
medicines
million
month
moves
news
noteworthy
o’day
plans
Language
unset
Current search:
help
×
fda
×
" life sciences "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More